56 / 64
S54
AFRICA
CVJAFRICA • Volume 26, No 2, H3Africa Supplement, March/April 2015
References
1.
Piel FB,Patil AP
,
Howes RE,
et al
. Global epidemiology of sickle
haemoglobin in neonates: a contemporary geostatistical model-based
map and population estimates.
Lancet2013;
381
(9861): 142–151.
2.
Platt OS,
Orkin SH,Dover G
,
et al.
Hydroxyurea enhances fetal
hemoglobin production in sickle cell anemia.
J Clin Invest1984;
74
(2):
652–656.
3.
Yanni E, Grosse SD,
Yang Q, Olney RS. Trends in pediatric sickle cell
disease-related mortality in the United States, 1983-2002.
J Pediatr2009;
154
(4): 541–545.
4.
Rahimy MC,
Gangbo A, Ahouignan G,et al
. Effect of a comprehen-
sive clinical care program on disease course in severely ill children with
sickle cell anemia in a sub-Saharan African setting.
Blood2003;
102
(3):
834–838.
5.
Vichinsky EP. Comprehensive care in sickle cell disease: its impact on
morbidity and mortality.
Semin Hematol
1991;
28
(3): 220–226.
6.
Piel FB,
Hay SI, Gupta S,
Weatherall DJ,
Williams TN. Global burden
of sickle cell anaemia in children under five, 2010–2050: modelling based
on demographics, excess mortality, and interventions.
PLoS Med2013;
10
(7): e1001484.
7.
Makani J,
Cox SE,Soka D
,
et al
. Mortality in sickle cell anemia in
Africa: a prospective cohort study in Tanzania.
PLoS One2011;
6
(2):
e14699.
8.
Lettre G,
Sankaran VG,Bezerra MA,
et al
. DNA polymorphisms at
the
BCL11A
,
HBS1L-MYB
, and beta-globin loci associate with fetal
hemoglobin levels and pain crises in sickle cell disease.
Proc Natl Acad Sci USA2008;
105
(33): 11869–11874.
9.
Thein SL, Menzel S. Discovering the genetics underlying foetal haemo-
globin production in adults.
Br J Haematol2009;
145
(4): 455–467.
10.
Bae HT,
Baldwin CT,
Sebastiani P,
et al
. Meta-analysis of 2040 sickle
cell anemia patients:
BCL11A
and
HBS1L-MYB
are the major modi-
fiers of HbF in African Americans.
Blood2012;
120
(9): 1961–1962.
11.
Xu J, Peng C,
Sankaran VG,
et al
. Correction of sickle cell disease in
adult mice by interference with fetal hemoglobin silencing.
Science2011;
334
(6058): 993–996.
12.
Bauer DE,Kamran SC
,
Lessard S,
et al.
An erythroid enhancer of
BCL11A
subject to genetic variation determines fetal hemoglobin level.
Science2013;
342
(6155): 253–257.
13. Makani J, Menzel S, Nkya S,
et al
.
Genetics of fetal hemoglobin in Tanzanian and British patients with sickle cell anemia.Blood
2011;
117
(4): 1390–1392.
14. Wonkam A, Ngo Bitoungui VJ, Vorster AA,
et al
.
Association of vari- ants at BCL11A and HBS1L-MYB with hemoglobin F and hospitali- zation rates among sickle cell patients in Cameroon.PLoS One
2014;
9
(3): e92506.
15. Bitoungui VJ, Ngogang J, Wonkam A.
Polymorphism at BCL11A compared to HBS1L-MYB loci explains less of the variance in HbF in patients with sickle cell disease in Cameroon.Blood Cells Mol Dis
2014
Nov 25. pii: S1079-9796(14)00143-0.
16. Menzel S, Rooks H, Zelenika D,
et al
.
Global Genetic Architecture of an Erythroid Quantitative Trait Locus, HMIP-2 .Ann Hum Genet
2014
Jul 29. doi:
10.1111/ahg.12077.
17. Ngo Bitoungui VJ, Pule GD, Hanchard N, Ngogang J, Wonkam A.
Beta-globin gene haplotypes among Cameroonians and review of
the global distribution: is there a case for a single sickle mutation
origin in Africa?
OMICS J Integrat Biol
2015;
19
(3): DOI:
10.1089/ omi.2014.0134.
18.
Solovieff N,
Milton JN,
Hartley SW,
et al
. Fetal hemoglobin in sickle
cell anemia: genome-wide association studies suggest a regulatory region
in the 5
′
olfactory receptor gene cluster.
Blood2010;
115
(9): 1815–1822.
19. Mtatiro SN, Singh T, Rooks H,
et al
.
Genome wide association study of fetal hemoglobin in sickle cell anemia in Tanzania.PLoS One
2014;
9
(11): e111464.
20.
Hsu LL, Miller ST,
Wright E,et al
.
Stroke Prevention Trial (STOP) and the Cooperative Study of Sickle Cell Disease (CSSCD).Alpha
thalassemia is associated with decreased risk of abnormal transcranial
Doppler ultrasonography in children with sickle cell anemia.
J Pediatr Hematol Oncol2003;
25
(8): 622–628.
21. Embury SH, Dozy AM, Miller J,
et al.
Concurrent sickle-cell anemia and alpha-thalassemia: effect on severity of anemia.N Engl J Med
1982;
306
(5): 270–274.
22.
Wonkam A,
Rumaney MB,
Ngo Bitoungui VJ,
et al
.
Coinheritance of sickle cell anemia and α -thalassemia delays disease onset and could improve survival in Cameroonian’s patients (Sub-Saharan Africa).Am J
Hematol
2014;
89
(6): 664–665.
23. Rumaney MB, Ngo Bitoungui VJ, Vorster AA,
et al
. The co-inheritance
of alpha-thalassemia and sickle cell anemia is associated with better
hematological indices and lower consultations rate in Cameroonian
patients and could improve their survival.
PLoS One2014;
9
(6):
e100516.
24. Cox SE, Makani J, Soka D,
et al
.
Haptoglobin, alpha-thalassaemia and glucose-6-phosphate dehydrogenase polymorphisms and risk of abnormal transcranial Doppler among patients with sickle cell anaemia in Tanzania.Br J Haematol
2014;
165
(5): 699–706.
25. Flanagan JM, Sheehan V, Linder H,
et al
.
Genetic mapping and exome sequencing identify 2 mutations associated with stroke protec- tion in pediatric patients with sickle cell anemia.
Blood
2013;
121
(16):
3237–3245.
26. Ohene-Frempong K, Weiner SJ, Sleeper LA,
et al
. Cerebrovascular
accidents in sickle cell disease: rates and risk factors.
Blood
1998;
91
(1):
288–294.
27. Njamnshi AK, Mbong EN, Wonkam A,
et al
.
The epidemiology of stroke in sickle cell patients in Yaounde, Cameroon.J Neurol Sci
2006;
250
(1–2): 79–84.
28. Njamnshi AK, Wonkam A, Djientcheu Vde P,
et al
.
Stroke may appear to be rare in Saudi Arabian and Nigerian children with sickle cell disease, but not in Cameroonian sickle cell patients.Br J Haematol
2006;
133
(2): 210.
29. Aliyu ZY, Gordeuk V, Sachdev V,
et al
.
Prevalence and risk factors for pulmonary artery systolic hypertension among sickle cell disease patients in Nigeria.Am J Hematol
2008;
83
(6): 485–490.
30.
DeBaun MR,Armstrong FD
,
McKinstry RC,
et al
. Silent cerebral
infarcts: a review on a prevalent and progressive cause of neurologic
injury in sickle cell anemia.
Blood2012;
119
(20): 4587–4596.
31. Ruffieux N, Njamnshi AK, Wonkam A,
et al
.
Association between biological markers of sickle cell disease and cognitive functioning amongst Cameroonian children.Child Neuropsychol
2013;
19
(2):
143–160.
32.
Lagunju I,
Sodeinde O,
Telfer P. Prevalence of transcranial Doppler
abnormalities in Nigerian children with sickle cell disease.
Am J Hematol2012;
87
(5): 544–547.
33. Makani J, Kirkham FJ, Komba A,
et al
.
Risk factors for high cerebral blood flow velocity and death in Kenyan children with sickle cell anae- mia: role of haemoglobin oxygen saturation and febrile illness.Br J
Haematol
2009;
145
(4): 529–532.
34. Gladwin MT, Sachdev V, Jison ML, et al. Pulmonary hypertension as
a risk factor for death in patients with sickle cell disease.
N Engl J Med
2004;
350
: 886–895.
35. Aliyu ZY, Kato GJ, Taylor J 6th,
et al
.
Sickle cell disease and pulmonary hypertension in Africa: a global perspective and review of epidemiology,